← Back to Search

Mindset Intervention for Cancer

N/A
Waitlist Available
Led By Alia Crum
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants receiving at least one course of systemic treatment
Individuals who have not received prior therapy for cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

This trial is studying the effects of a patient's mindset on cancer treatment outcomes.

Who is the study for?
This trial is for English-speaking adults over 18 with a new diagnosis of lung, breast, GI/colorectal cancer or lymphoma and treatment aimed at curing it. They must be able to consent and undergo systemic treatment involving 4-12 infusions. Excluded are those with major health issues reducing life expectancy, active severe mental health diagnoses, pregnant/nursing women, HIV-positive individuals or previous cancer treatments.Check my eligibility
What is being tested?
The study tests how mindsets affect health outcomes in cancer patients. It involves reflection activities designed to promote beneficial views about cancer and the body's role during recovery. Participants will be randomly assigned to either these mindset interventions or their usual care without the added activities.See study design
What are the potential side effects?
Since this trial focuses on psychological interventions rather than medications, traditional side effects like those seen with drugs are not expected. However, participants may experience emotional discomfort when engaging in deep reflection about their illness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have undergone at least one round of systemic therapy.
Select...
I have not received any treatment for cancer before.
Select...
I was treated for cancer (breast, lung, GI/colorectal, or lymphoma) with the goal of curing it.
Select...
My treatment plan involves 4 to 12 infusions.
Select...
I am 18 or older, speak English fluently, and do not have cognitive impairments.
Select...
I have lung, breast, GI/Colorectal cancer, or Lymphoma and am being treated to cure it.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Quality of Life Survey
Secondary outcome measures
Biomarker Analyses
Fear of Cancer Recurrence
Measuring affect with cancer
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mindset InterventionExperimental Treatment2 Interventions
Mindset Intervention will include watching three brief ~10-25 minute films and respond to a number of short reflection activities after viewing the films.
Group II: Treatment As Usual (TAU)Active Control1 Intervention
TAU Control Arm will complete the same assessments as those participants in the Mindset Intervention Arm, but will not view the short films or complete the corresponding response activities.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,383 Previous Clinical Trials
17,333,770 Total Patients Enrolled
Alia CrumPrincipal InvestigatorStanford University

Media Library

Mindset Clinical Trial Eligibility Overview. Trial Name: NCT04020029 — N/A
Cancer Research Study Groups: Mindset Intervention, Treatment As Usual (TAU)
Cancer Clinical Trial 2023: Mindset Highlights & Side Effects. Trial Name: NCT04020029 — N/A
Mindset 2023 Treatment Timeline for Medical Study. Trial Name: NCT04020029 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new enrollees currently being accepted into this research trial?

"Per the data hosted on clinicaltrials.gov, this trial stopped recruiting patients in October of 2022. Initially posted on 11/1/2022 there are currently 486 other medical studies that require patient participants."

Answered by AI
~80 spots leftby Nov 2024